[Sirt1 inhibited oxidized low-density lipoprotein induced smooth muscle cells inflammatory response]

Area of Science:

• Cardiovascular Biology
• Molecular Mechanisms of Atherosclerosis
• Cellular Inflammation

Background:

• Atherosclerosis involves inflammation of smooth muscle cells.
• Oxidized low-density lipoprotein (oxLDL) is implicated in atherosclerotic plaque development.
• The role of Sirtuin 1 (Sirt1) in oxLDL-induced smooth muscle cell inflammation requires elucidation.

Purpose of the Study:

• To investigate the mechanism by which oxLDL induces smooth muscle cell inflammation via Sirt1.
• To determine the expression levels of Sirt1 in atherosclerotic plaques.
• To assess the impact of Sirt1 modulation on oxLDL-induced inflammatory responses and reactive oxygen species (ROS) generation.

Main Methods:

• Quantified Sirt1 expression in human and mouse atherosclerotic plaque tissues.
• Utilized overexpression of Sirt1 in smooth muscle cells.
• Measured inflammatory cytokine secretion and ROS generation in response to oxLDL and Sirt1 modulation.

Main Results:

• Sirt1 expression was significantly decreased in the smooth muscle cell regions of human and mouse atherosclerotic plaques.
• Oxidized low-density lipoprotein (oxLDL) exposure increased inflammatory cytokine secretion and ROS generation.
• Upregulation of Sirt1 reversed the pro-inflammatory and pro-oxidative effects of oxLDL.

Conclusions:

• Oxidized low-density lipoprotein (oxLDL) regulates smooth muscle cell inflammatory responses through Sirt1.
• Sirt1 acts as a key signaling molecule in modulating smooth muscle cell inflammation during atherosclerosis.
• Targeting Sirt1 may offer a therapeutic strategy for atherosclerosis.